Publication|Articles|March 4, 2024
Supplements and Featured Publications
- Summary of the CLEAR Outcomes Trial
Summary of the CLEAR Outcomes Trial
Advertisement
This clinical brief is intended to increase awareness among managed care decision-makers about the results of the CLEAR Outcomes trial, a cardiovascular outcomes trial for bempedoic acid, as well as foster informed decision-making among managed care decision-makers on the place in therapy for bempedoic acid in patients with high risk or with cardiovascular disease who need additional lipid lowering.
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
Tec-Dara Demonstrates Superior 3-Year PFS vs Standard Therapy in Functional High-Risk Myeloma: Rahul Banerjee, MD
2
EHA 2026 Late Breakers Deliver Practice-Shifting Phase 3 Data and Novel CAR T Approaches Across Hematology
3
MRD-Guided CLL Treatment Duration: Personalization or Malpractice?
4
Global Hematology Trials Ensure Research Stays Applicable, Flexible, Patient-Centered
5